Search found 7 matches

by Fred3582
Wed Sep 27, 2023 4:21 am
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hello,

Please check out this today's video by Dr Brandon Beaber about temelimab for MS :

by Fred3582
Sat Sep 23, 2023 11:51 am
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hello, An interesting video by Dr Brandon Beaber : does the retrovirus HERV-w cause Multiple Sclerosis? This hypothesis is linked to the subject of temelimab, a specific monoclonal antibody designed to neutralize the envelope protein of this retrovirus. Next week dr Beaber will talk about temelimab ...
by Fred3582
Sat Oct 29, 2022 3:14 am
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hi, These results have been presented at the ECTRIMS 2022 congress (10/27) in Amsterdam by dr Frederik Piehl, from the Karolinska Institutet in Sweden. "GeNeuro’s ProTEct-MS Phase 2 Trial Data, Presented at the ECTRIMS 2022 Congress in Amsterdam, Confirms Synergistic Neuroprotective Potential o...
by Fred3582
Thu Mar 24, 2022 2:00 pm
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hello,

Watch the comments of these results hereby, if you are interested :smile:

by Fred3582
Tue Mar 22, 2022 11:03 am
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hello,

Here's a link to the presentation of these top-line results:

http://www.geneuro.ch/data/documents/GN ... 22-ENG.pdf

:-D
by Fred3582
Sun Mar 20, 2022 11:27 pm
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2/RESULTS

Hello, good news :-D, The results of the phase 2 trial with temelimab announced today: "ProTEct-MS Phase 2 Trial Confirms Safety of Higher Doses of Temelimab and Synergistic Potential to Address Neurodegeneration on Top of Anti-inflammatory Treatment in Multiple Sclerosis..." More here: ht...
by Fred3582
Sat Feb 19, 2022 4:00 am
Forum: Drug Pipeline
Topic: MSRV Retrovirus, phase 2
Replies: 76
Views: 44159

Re: MSRV Retrovirus, phase 2

Hello, the PRoTEct-MS study with temelimab is completed and the top-line results to be announced in march 2022 :-D : https://www.businesswire.com/news/home/20220126005832/en/GeNeuro-Announces-the-Completion-of-Its-ProTEct-MS-Study-and-Confirms-the-March-Timeline-for-Top-line-Results-Provides-a-Busin...

Go to advanced search